Michelle Robertson's Net Worth
$962 Thousand
Who is Michelle Robertson?
Michelle Robertson does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Editas Medicine, Inc., Verastem, Inc., MOMENTA PHARMACEUTICALS INC, and GERON CORP.
SEC CIK
Michelle Robertson's CIK is 0001755098
Past Insider Trading and Trends
2021 was Michelle Robertson's most active year for acquiring shares with 6 total transactions. Michelle Robertson's most active month to acquire stocks was the month of January. 2019 was Michelle Robertson's most active year for disposing of shares, totalling 7 transactions. Michelle Robertson's most active month to dispose stocks was the month of January. 2021 saw Michelle Robertson paying a total of $153,250.00 for 115,464 shares, this is the most they've acquired in one year. In 2021 Michelle Robertson cashed out on 11,568 shares for a total of $397,727.36, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Editas Medicine, Inc. (EDIT) Snapshot price: $3.57
EVP, CHIEF FINANCIAL OFFICER
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -0.88% | -949.00 |
$9.87 | -$9,368.53 | 106.61K |
May 11
| |||
Form 4
| +41.07% | 31.32K |
$8.89 | -$1,635.76 | 107.56K |
Mar 2 - Mar 3
| |||
Form 4
| -5.32% | -4.29K |
$9.67 | -$41,435.14 | 76.24K |
Feb 13
| |||
Form 4
| -2.13% | -1.75K |
$8.16 | -$14,296.50 | 80.53K |
Jan 10
| |||
Form 4
| -0.23% | -193.00 |
$10.23 | -$1,974.39 | 82.28K |
Dec 5
| |||
Form 4
| -0.23% | -192.00 |
$15.01 | -$2,881.92 | 82.47K |
Sep 6
| |||
Form 4
| -1.81% | -1.53K |
$11.54 | -$17,616.85 | 82.67K |
Jun 3
| |||
Form 4
| -0.90% | -767.00 |
$17.33 | -$13,290.35 | 84.19K |
Mar 3
| |||
Form 4
| +170.04% | 53.5K |
—
|
—
| 84.96K |
Feb 10
| |||
Form 4
| -5.25% | -1.74K |
$25.70 | -$44,820.80 | 31.46K |
Jan 11
| |||
Form 4
| +15.56% | 4.47K |
—
|
—
| 33.21K |
Dec 22
| |||
Form 4
|
—
|
0
|
$45.33 | -$73,375.00 | 28.73K |
Scheduled
|
Aug 9
| ||
Form 4
|
—
|
0
|
$40.33 | -$48,375.00 | 28.73K |
Scheduled
|
Jun 28
| ||
Form 4
| +55.90% | 10.3K |
—
|
—
| 28.73K |
Mar 2
| |||
Form 4
| -7.84% | -1.57K |
$78.27 | -$122,727.36 | 18.43K |
Jan 12
| |||
Form 4
|
∞
| 20K |
—
|
—
| 20K |
Jan 9
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Verastem, Inc. (VSTM) Snapshot price: $2.44
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 8.33K |
—
|
—
| 8.33K |
Jun 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 15
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
May 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 15
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
MOMENTA PHARMACEUTICALS INC No price found
Chief Financial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -49.96% | -6.80K |
$15.00 | -$102,030.00 | 6.81K |
Scheduled
|
Oct 25
| ||
Form 4
| +100.19% | 6.81K |
$13.83 | -$40,604.88 | 13.62K |
Scheduled
|
Oct 17 - Oct 18
| ||
Form 4
| -40.99% | -4.72K |
—
|
—
| 6.8K |
Apr 13
| |||
Form 4
| -5.75% | -703.00 |
$13.10 | -$9,209.30 | 11.53K |
Scheduled
|
Feb 14
| ||
Form 4
| +39.46% | 3.46K |
$12.70 | -$17,907.00 | 12.23K |
Scheduled
|
Feb 12 - Feb 13
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 17
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
GERON CORP (GERN) Snapshot price: $4.29
EVP, Chief Financial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 25
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||